Ultra-high-field Brain MRI in Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 12, 2023

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions
Multiple Sclerosis
Interventions
DIAGNOSTIC_TEST

Brain MRI (3T, 7T, 9.4T)

All patients will undergo anatomical brain imaging on a 3T, 7T and 9.4T MRI scanner within the same day at baseline and again 6 months later. An optimized protocol for every separate field strength will be run. Sequences will include at least T1-weighted, T2\*-weighted and a T2 SPACE or FLAIR sequence. No intravenous contrast will be used.

Trial Locations (1)

6162BG

Zuyderland MC, Geleen

All Listed Sponsors
collaborator

Scannexus

UNKNOWN

lead

Zuyderland Medisch Centrum

OTHER

NCT05718947 - Ultra-high-field Brain MRI in Multiple Sclerosis | Biotech Hunter | Biotech Hunter